Severe acute cerebrovascular disease revealing hepatitis C virus infection: Effectiveness of alpha-interferon

E. Marchioni, M. Ceroni, A. Erbetta, E. Alfonsi, M. Bottanelli, F. Imbesi, G. Ricevuti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

It is well known that hepatitis C virus (HCV) can be associated with cryoglobulinemia- induced central and peripheral nervous system disorders, even without significant hepatic damage. The effectiveness of alpha interferon treatment was tested in a small series of patients with controversial results. We present here a case of a previously undetected HCV infection announced by acute and severe multifocal cerebrovascular disease with polyneuropathy. We also report the favorable effects of timely alpha interferon treatment on the main clinical and laboratory disease markers.

Original languageEnglish
Pages (from-to)1111-1113
Number of pages3
JournalJournal of Neurology
Volume249
Issue number8
DOIs
Publication statusPublished - 2002

Fingerprint

Cerebrovascular Disorders
Acute Disease
Virus Diseases
Interferon-alpha
Hepacivirus
Cryoglobulinemia
Polyneuropathies
Central Nervous System Diseases
Peripheral Nervous System Diseases
Biomarkers
Liver
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Severe acute cerebrovascular disease revealing hepatitis C virus infection : Effectiveness of alpha-interferon. / Marchioni, E.; Ceroni, M.; Erbetta, A.; Alfonsi, E.; Bottanelli, M.; Imbesi, F.; Ricevuti, G.

In: Journal of Neurology, Vol. 249, No. 8, 2002, p. 1111-1113.

Research output: Contribution to journalArticle

@article{b165d40e50054a819297e605af9747db,
title = "Severe acute cerebrovascular disease revealing hepatitis C virus infection: Effectiveness of alpha-interferon",
abstract = "It is well known that hepatitis C virus (HCV) can be associated with cryoglobulinemia- induced central and peripheral nervous system disorders, even without significant hepatic damage. The effectiveness of alpha interferon treatment was tested in a small series of patients with controversial results. We present here a case of a previously undetected HCV infection announced by acute and severe multifocal cerebrovascular disease with polyneuropathy. We also report the favorable effects of timely alpha interferon treatment on the main clinical and laboratory disease markers.",
author = "E. Marchioni and M. Ceroni and A. Erbetta and E. Alfonsi and M. Bottanelli and F. Imbesi and G. Ricevuti",
year = "2002",
doi = "10.1007/s00415-002-0730-4",
language = "English",
volume = "249",
pages = "1111--1113",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "8",

}

TY - JOUR

T1 - Severe acute cerebrovascular disease revealing hepatitis C virus infection

T2 - Effectiveness of alpha-interferon

AU - Marchioni, E.

AU - Ceroni, M.

AU - Erbetta, A.

AU - Alfonsi, E.

AU - Bottanelli, M.

AU - Imbesi, F.

AU - Ricevuti, G.

PY - 2002

Y1 - 2002

N2 - It is well known that hepatitis C virus (HCV) can be associated with cryoglobulinemia- induced central and peripheral nervous system disorders, even without significant hepatic damage. The effectiveness of alpha interferon treatment was tested in a small series of patients with controversial results. We present here a case of a previously undetected HCV infection announced by acute and severe multifocal cerebrovascular disease with polyneuropathy. We also report the favorable effects of timely alpha interferon treatment on the main clinical and laboratory disease markers.

AB - It is well known that hepatitis C virus (HCV) can be associated with cryoglobulinemia- induced central and peripheral nervous system disorders, even without significant hepatic damage. The effectiveness of alpha interferon treatment was tested in a small series of patients with controversial results. We present here a case of a previously undetected HCV infection announced by acute and severe multifocal cerebrovascular disease with polyneuropathy. We also report the favorable effects of timely alpha interferon treatment on the main clinical and laboratory disease markers.

UR - http://www.scopus.com/inward/record.url?scp=0036040961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036040961&partnerID=8YFLogxK

U2 - 10.1007/s00415-002-0730-4

DO - 10.1007/s00415-002-0730-4

M3 - Article

C2 - 12420713

AN - SCOPUS:0036040961

VL - 249

SP - 1111

EP - 1113

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 8

ER -